Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
38.03-0.05 (-0.13%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close38.08
Bid37.05 x 100
Ask39.20 x 100
Day's Range37.05 - 39.26
52wk Range33.50 - 99.46
1y Target EstN/A
Market Cap1.45B
P/E Ratio (ttm)-8.97
Avg Vol (3m)725,704
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETF’s with exposure to Agios Pharmaceuticals, Inc. : August 26, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Agios Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to AGIO-US. Comparing the performance and risk of Agios Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Benzinga9 days ago

    Why This Analyst Is Awaiting More Efficacy Signals For Agios Pharma Candidates

    BTIG analyst Ling Wang initiated coverage on Agios Pharmaceuticals Inc (NASDAQ: AGIO ) shares with a Neutral rating, citing balanced risk/reward at current levels. The brokerage is waiting for the company ...

  • GlobeNewswire12 days ago

    Agios Appoints Andrew Hirsch as Chief Financial Officer

    CAMBRIDGE, Mass., Aug. 16, 2016-- Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced that Andrew Hirsch is joining the company ...